Mechanistic studies of stalled DNA replication fork rescue

Information

  • Research Project
  • 10387612
  • ApplicationId
    10387612
  • Core Project Number
    R01GM100156
  • Full Project Number
    3R01GM100156-09S1
  • Serial Number
    100156
  • FOA Number
    PA-20-272
  • Sub Project Id
  • Project Start Date
    6/7/2013 - 11 years ago
  • Project End Date
    4/30/2022 - 2 years ago
  • Program Officer Name
    REDDY, MICHAEL K
  • Budget Start Date
    8/1/2020 - 4 years ago
  • Budget End Date
    4/30/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    09
  • Suffix
    S1
  • Award Notice Date
    9/13/2021 - 3 years ago

Mechanistic studies of stalled DNA replication fork rescue

ABSTRACT OF THE PARENT GRANT GM10056 There is a fundamental gap in understanding how stalled DNA replication forks are rescued. The continued existence of this gap represents an important problem because, until it is filled, a complete and clear understanding of the mechanism of stalled fork reactivation will be lacking. This understanding is crucial as defects in these repair mechanisms in higher organisms lead to the accumulation of mutations leading to cancer, and the proposed studies are therefore directly relevant to human disease. Consequently, the long-term goal is to understand the mechanism of stalled DNA replication fork reactivation. The main objective of this proposal is to understand the interplay between the single-stranded DNA binding protein (SSB) and key fork rescue enzymes on nucleoid templates and of the subsequent processing events leading to restoration of a fork structure. To achieve this objective, this proposal is divided into three specific aims: 1), Determine the mechanism(s) of fork regression; 2,) To determine how fork impediments affect fork regression; and 3), Ascertain the effects of nucleoid-associated proteins on fork rescue enzymes. Under the first aim, magnetic tweezers and atomic force microscopy (both in air and high-speed in buffer) will be used to determine how SSB loading and regression by RecG are affected by PriA and to ascertain whether RecA and RuvAB are able to catalyze an efficient and unidirectional fork regression reaction. When the proposed studies for Aim 1 are complete, a clear picture of the events at a nascent, stalled replication fork will be provided. Under the second aim, the same two single DNA molecule approaches will be used to provide insight into the effects of replisome impediments on stalled fork rescue, with high spatial and temporal resolution. At the conclusion of the proposed studies for Aim 2, the effects of DNA lesions and protein-DNA complexes on fork rescue will be made clear and it is anticipated that the mechanism(s) for displacing stalled RNA polymerase in the vicinity of forks will be obtained. Under the final aim, magnetic tweezers to manipulate single molecules of DNA will be used to ascertain the effects of nucleoid- associated proteins (NAPs) on fork rescue. When the proposed studies for Aim 3 are complete, it will be ascertained whether NAPs catalyze regression on their own and if they assist or inhibit fork rescue enzymes. The proposed research is innovative because of the combinatorial strategy taken. It is also innovative because of the exciting and novel single-molecule approaches used, the focus on nucleoid templates, and an understanding to be gained of how the primary protein barrier(s) causing replisome stalling are removed. Finally, the work is also innovative because of the care taken in elucidating how recombination helicases function in the presence of SSB. The proposed research is significant because it will allow, for the first time, the development of clear models of the mechanistic events occurring at a stalled fork embedded within nucleoid templates and, it will provide the first real-time insight into the range of events that transpire to reactivate a stalled fork in vivo.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R01
  • Administering IC
    GM
  • Application Type
    3
  • Direct Cost Amount
    60174
  • Indirect Cost Amount
  • Total Cost
    60174
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
    SCHOOLS OF PHARMACY
  • Funding ICs
    NIGMS:60174\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
  • Study Section Name
  • Organization Name
    UNIVERSITY OF NEBRASKA MEDICAL CENTER
  • Organization Department
    OTHER BASIC SCIENCES
  • Organization DUNS
    168559177
  • Organization City
    OMAHA
  • Organization State
    NE
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    681987835
  • Organization District
    UNITED STATES